Secondary C805S Mutation in HER2 Gene Confers Acquired Resistance to HER2 Kinase Inhibitors in HER2 Mutant Lung Cancer

被引：0

作者：

Kosaka, Takayuki ^{[1
]}

Endoh, Hideki ^{[1
]}

Repellin, Claire ^{[1
]}

Tanizaki, Junko ^{[1
]}

Ercan, Dalia ^{[1
]}

Capelletti, Marzia ^{[1
]}

Jaenne, Pasi A. ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期

关键词：

HER2; NSCLC; Acquired resistance; Target therapy;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MINI09.08

引用

页码：S296 / S296

页数：1

共 50 条

[1] Acquired Secondary HER2 Mutations Enhance HER2/MAPK Signaling and Promote Resistance to HER2 Kinase Inhibition in Breast Cancer
Marin, Arnaldo
Al Mamun, Abdullah
Patel, Hima
Akamatsu, Hiroaki
Ye, Dan
Sudhan, Dhivya R.
Eli, Lisa
Marcelain, Katherine
Brown, Benjamin P.
Meiler, Jens
Arteaga, Carlos L.
Hanker, Ariella B.
CANCER RESEARCH, 2023, 83 (18) : 3145 - 3158
[2] HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer
Hou, Yanjun
Nitta, Hiroaki
Li, Zaibo
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (01) : 89 - 95
[3] HER2 or not HER2: That is the question
Burstein, HJ
Winer, EP
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 3656 - 3659
[4] Defining the spectrum and "overlap" of HER2 aberrations in lung cancers: Associations of HER2 protein overexpression, HER2 amplification, and HER2 mutation. 8067
Li, Bob T.
Ross, Dara S.
Chaft, Jamie E.
Hsu, Meier
Kako, Severine
Aisner, Dara L.
Kris, Mark G.
Varella-Garcia, Marileila
Arcila, Maria E.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[5] HER2 and lung cancer
Landi, Lorenza
Cappuzzo, Federico
EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (10) : 1219 - 1228
[6] HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors
Wang, Shizhen Emily
Narasanna, Archana
Perez-Torres, Marianela
Xiang, Bin
Wu, Frederick Y.
Yang, Seungchan
Carpenter, Graham
Gazdar, Adi F.
Muthuswamy, Senthil K.
Arteaga, Carlos L.
CANCER CELL, 2006, 10 (01) : 25 - 38
[7] HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers
Li, Bob T.
Ross, Dara S.
Aisner, Dara L.
Chaft, Jamie E.
Hsu, Meier
Kako, Severine L.
Kris, Mark G.
Varella-Garcia, Marileila
Arcila, Maria E.
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (03) : 414 - 419
[8] Investigation of intracellular dynamics of HER2 and effect of HER2-ADC in HER2 mutation-positive lung cancer
Shimauchi, Atsushi
Iwama, Eiji
Ibusuki, Ritsu
Shibahara, Daisuke
Otsubo, Kohei
Yoneshima, Yasuto
Okamoto, Isamu
CANCER SCIENCE, 2025, 116 : 231 - 231
[9] HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer
Xu, Xiaowei
De Angelis, Carmine
Burke, Kathleen A.
Nardone, Agostina
Hu, Huizhong
Qin, Lanfang
Veeraraghavan, Jamunarani
Sethunath, Vidyalakshmi
Heiser, Laura M.
Wang, Nicholas
Ng, Charlotte K. Y.
Chen, Edward S.
Renwick, Alexander
Wang, Tao
Nanda, Sarmistha
Shea, Martin
Mitchell, Tamika
Rajendran, Mahitha
Waters, Ian
Zabransky, Daniel J.
Scott, Kenneth L.
Gutierrez, Carolina
Nagi, Chandandeep
Geyer, Felipe C.
Chamness, Gary C.
Park, Ben H.
Shaw, Chad A.
Hilsenbeck, Susan G.
Rimawi, Mothaffar F.
Gray, Joe W.
Weigelt, Britta
Reis-Filho, Jorge S.
Osborne, C. Kent
Schiff, Rachel
CLINICAL CANCER RESEARCH, 2017, 23 (17) : 5123 - 5134
[10] Evaluation of analytical accuracy of HER2 status in patients with breast cancer Comparison of HER2 GPA with HER2 IHC and HER2 FISH
Jensen, Steffen Grann
Thomas, Peter Engel
Christensen, Ib Jarle
Balslev, Eva
Hansen, Alastair
Hogdall, Estrid
APMIS, 2020, 128 (11) : 573 - 582

← 1 2 3 4 5 →